| Predicate |
Object |
| contentType |
Journal Article|Review |
| endingPage |
376 |
| issn |
0920-3206
1573-7241 |
| issueIdentifier |
3 |
| pageRange |
369-376 |
| publicationName |
Cardiovascular Drugs and Therapy |
| startingPage |
369 |
| bibliographicCitation |
Opie LH. Role of vasodilation in the antihypertensive and antianginal effects of labetalol: implications for therapy of combined hypertension and angina. Cardiovasc Drugs Ther. 1988 Sep;2(3):369–76. doi: 10.1007/bf00054645. PMID: 3154919. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6870afb382ce9080132a5f323efef78d |
| date |
198809 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/3154919
https://doi.org/10.1007/bf00054645 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1847
https://portal.issn.org/resource/ISSN/1573-7241
https://portal.issn.org/resource/ISSN/0920-3206 |
| language |
English |
| source |
https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Role of vasobilation in the antihypertensive and antianginal effects of labetalol: Implications for therapy of combined hypertension and angina |
| discusses |
http://id.nlm.nih.gov/mesh/M0001456
http://id.nlm.nih.gov/mesh/M0012098 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID943
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4946
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6985
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2249 |